Please login to the form below

Not currently logged in
Email:
Password:

UK Dementia Research Institute names director

Prof Bart De Strooper to lead the national institute

UK Dementia Research Prof Bart De StrooperProf Bart De Strooper has been appointed as director of the UK Dementia Research Institute, and will lead the venture from University College London.

In his new role, Prof De Strooper will work with the institute's founding partners - the Medical Research Council, Alzheimer's Society and Alzheimer's Research UK - to develop new therapeutics and diagnostics to accelerate the pace of dementia research.

Prof De Strooper is currently a professor of molecular medicine at the University of Leuven and leads its laboratory for the research of neurodegenerative diseases.

He also serves as the departmental director of the VIB Center for the Biology of Disease at VIB at the Flemish Institute for Biotechnology, and has been a visiting professor at UCL since 2013.

Prof De Strooper said: “I am delighted to be directing a world-leading initiative with as much as potential as the UK DRI.

“The UK research landscape is brimming with talent and opportunity and, thanks to the NHS, research is closely allied to patients.

“My vision is to establish a unique environment with a diverse and interdisciplinary team ready to undertake creative and innovative research.”

He added: “I want the Institute to be the most exciting place in the world for breakthrough dementias research.

“To achieve this we need to not only join forces and facilitate closer interaction between leading groups currently working in this area, but also bring together talented scientists in completely different and previously overlooked fields that could contribute towards our understanding of the dementias.

“We have a huge amount of discovery science to do - and I want to see real surprises.”

16th December 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics